BMRN

BioMarin Pharmaceutical Inc. Common Stock

BMRN · Salud · Next earnings: 26 Oct 2026 · Time not confirmed · Q3 2026

Relevance 45/100 · Minor

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

Company

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Sector Healthcare · Biotechnology
Website https://www.biomarin.com

What the market expects

ConsensusPrior-year EPS

EPS1.04—

Revenue1,024,715,630—

14 analysts

How expectations have moved

Expectations: Very low

Expectativas bajas: el consenso de BPA se ha revisado a la baja un 22.3% en 30 días y -16% en el último mes. Un resultado flojo puede estar ya descontado.

Stock, 90 days: -5.5%

Prior behaviour

Average absolute move: 2.6%
Largest move: 3.3%
releases with a move larger than 5%: 0%
beat the EPS consensus in: 2 of the last 4

Quarter Date 1-session move Surprise EPS

Jun 2026 06 Aug 2026 +2.6% +13.9%

Mar 2026 04 May 2026 +2.6% -25.6%

Dec 2025 23 Feb 2026 -1.8% +300.0%

Sep 2025 27 Oct 2025 -3.3% -109.8%

Historical moves describe typical magnitude, not a future direction.

Expected move

±2.6% (historical)

“±X%” is the typical move size, not a forecast of direction.

Stock situation

Price: 55.39
30 days: -15.7%
90 days: -5.5%
Distance to 52-week high: -22.0%
Market cap: 10,606,874,600

Metrics to watch

El trimestre anterior batió el consenso de BPA un 14%.
Ventas del fármaco o producto principal
Guidance de ingresos anual
Avances de pipeline / ensayos clínicos mencionados
Margen operativo
BPA e ingresos frente al consenso (sorpresa)
Cambio en el guidance respecto al trimestre anterior
Reacción del mercado frente al movimiento histórico y al implícito

Relevance breakdown

market_cap: 5.0
analyst_coverage: 5.6
estimate_revisions: 16.0
recent_price_move: 6.3
historical_earnings_vol: 3.9
sector_importance: 4.0
recent_news_coverage: 0.0

Disclaimer

Radar Acciones provides information and analysis tools, not personalised investment advice. Consensus and expectations data describe the setup around an event with objective figures; they must never be read as a forecast of direction or price.